Can You Remove Calcium From Your Arteries?

No proven therapy can dissolve or fully reverse calcium deposits already embedded in your artery walls. Once calcium crystallizes into hydroxyapatite, the same mineral found in bone, it becomes extremely stable and resistant to removal by drugs, supplements, or diet changes. That does not mean the situation is hopeless. Medications can slow how fast new calcium accumulates, catheter-based procedures can physically crack through calcified blockages, and a handful of emerging treatments are being studied for their ability to halt the process at the molecular level. But the popular idea that you can flush calcium out of your arteries with a supplement or a detox protocol oversimplifies a biology that turns out to be stubbornly complex.

How Calcium Ends Up in Your Arteries

Arterial calcification is not simply calcium drifting through your blood and sticking to vessel walls. It is an active, cell-driven process that mirrors bone formation. Smooth muscle cells in the artery wall can shift their identity, switching on genes normally associated with bone-building cells called osteoblasts. When this happens, these cells start producing bone-related proteins and depositing a mineralized matrix right inside the vessel.

1PubMed Central. Mechanisms of the Osteogenic Switch of Smooth Muscle Cells in Vascular Calcification: WNT Signaling, BMPs, Mechanotransduction, and EndMT

Researchers have shown that smooth muscle cells placed under calcifying conditions in the lab lose their normal identity markers within about ten days and begin expressing bone-specific transcription factors like Cbfa1, along with proteins like osteopontin and osteocalcin. The same pattern shows up in animal arteries that spontaneously calcify.

2PubMed. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers

Your body also produces natural calcification inhibitors, including pyrophosphate and a protein called matrix Gla protein (MGP), which normally keep minerals from precipitating in soft tissue. Excessive calcification occurs when these protective mechanisms fail, whether from enzyme defects, mineral imbalances, or chronic disease. In other words, calcification is not just something that happens to you passively; it is something your body’s defenses failed to prevent.

3PubMed Central. Vascular Calcification: A Passive Process That Requires Active Inhibition

Two Types of Calcification, Two Different Problems

Not all arterial calcium is the same. Calcification can occur in two distinct layers of the artery wall, and the distinction matters for both risk and treatment. Intimal calcification happens within atherosclerotic plaques, the fatty buildups that narrow arteries and can rupture to cause heart attacks. Medial calcification happens in the muscular middle layer of the artery, stiffening the vessel without necessarily narrowing it. The two types have overlapping but different risk-factor profiles: smoking and high cholesterol tend to drive intimal calcification, while diabetes and elevated blood sugar are more strongly linked to medial calcification.

4PubMed Central. Intimal and medial calcification in relation to cardiovascular risk factors

Intimal calcification can make plaques unstable and lead to acute events like heart attacks. Medial calcification tends to cause arterial stiffness, which raises blood pressure and contributes to heart failure over time. When people ask about “removing calcium from arteries,” they usually mean the kind lodged in coronary plaques, but medial calcification is a major concern for people with diabetes or chronic kidney disease. The treatments that might help one type do not necessarily help the other.

The Statin Paradox

Statins are the most widely prescribed drugs for heart disease, and their track record for reducing heart attacks and strokes is strong. But here is something that confuses a lot of people: statins tend to increase coronary calcium scores, not decrease them. One study found that patients on statins saw their calcium scores rise by about 15% per year, compared to roughly 39% per year in untreated patients. Both groups gained calcium, just at different rates.

5PubMed. Rates of progression of coronary calcium by electron beam tomography

Longer statin use is associated with even higher calcium scores. A large analysis found that each additional year on a statin was linked to higher calcium score categories, with those on statins for over ten years showing substantially elevated odds of severe calcification compared to non-users.

6PubMed Central. Long-term statin therapy is associated with severe coronary artery calcification

This sounds alarming until you look at what kind of calcium statins produce. Imaging research has shown that statins do not simply add more calcium; they appear to transform plaque composition toward denser, more stable calcification while reducing the soft, lipid-rich plaque that is most prone to rupture. Patients on statins showed less progression of low-density calcium and greater progression of high-density calcium, a pattern associated with reduced overall atherosclerotic risk.

7JAMA Cardiology. Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition

High-intensity statin therapy has also been linked to actual regression of overall plaque volume, even as calcium content within those plaques continued to increase. In one large study, patients on high-intensity statins showed a small but meaningful reduction in total plaque burden, while those on lower-intensity statins or no statins saw plaque grow.

8PubMed. Impact of statins on serial coronary calcification during atheroma progression and regression

So statins do not remove calcium. They appear to stabilize it, packing it more tightly into a form less likely to cause a sudden event. Think of it as the difference between a crumbly, unstable wall and a solid concrete one: the concrete wall has more calcium in it, but it is far less dangerous. A rising calcium score on a statin does not necessarily mean your heart disease is getting worse.

Vitamin K2, Magnesium, and Other Supplement Claims

Vitamin K2 is the supplement most commonly promoted for “decalcifying” arteries. The logic is straightforward: vitamin K activates matrix Gla protein, one of the body’s key calcification inhibitors. Without enough vitamin K, MGP stays in its inactive form and cannot do its job. In one study of hemodialysis patients who already had vascular calcification, a year of vitamin K2 supplementation reduced inactive MGP levels by about 21% and median calcium scores by about 15%.

9Nephrology Dialysis Transplantation. Correlation Between Matrix Gla Protein Level and Effect of Vitamin K2 Therapy on Vascular Calcification in Hemodialysis Patients

That result is genuinely interesting, but it comes from a very specific population: people on dialysis, whose calcification biology is driven by extreme mineral imbalances. Whether vitamin K2 can do anything similar in otherwise healthy people with coronary artery calcium remains unproven. Larger, longer trials in general populations have not yet confirmed reversal of calcification with vitamin K2.

Magnesium is another supplement with plausible anti-calcification properties. Lab and animal studies indicate that magnesium can protect smooth muscle cells from shifting toward the bone-building phenotype that drives calcification.

10PubMed. Magnesium as a Calcification Inhibitor The evidence in humans is still mostly observational and preclinical, so magnesium supplements cannot be credited with removing existing calcium deposits based on current data.

Why Calcium Supplements Might Make Things Worse

Here is an ironic twist. While people search for ways to remove calcium from arteries, a common supplement may be adding it. In the Multi-Ethnic Study of Atherosclerosis, which tracked over 2,700 older adults for a decade, calcium supplement use was associated with about a 22% higher risk of developing new coronary artery calcium, even after accounting for total calcium intake from food.

11PubMed Central. Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification and its Progression Among Older Adults: 10-Year Follow-up of the Multi-Ethnic Study of Atherosclerosis (MESA)

A separate study using intravascular ultrasound confirmed that oral calcium supplementation independently predicted increases in coronary calcification, regardless of what was happening to overall plaque volume.

12PubMed. Oral Calcium Supplements Associate With Serial Coronary Calcification: Insights From Intravascular Ultrasound

The distinction seems to be between calcium from food, which enters the bloodstream slowly and is generally well regulated, and calcium from supplements, which can cause a sharp spike in blood calcium levels. That transient spike may overwhelm the body’s normal defenses against soft-tissue mineralization. If you are taking calcium supplements for bone health, this is worth discussing with your doctor, especially if you already have coronary calcium. Getting calcium from dietary sources like dairy or leafy greens appears to carry a different risk profile.

EDTA Chelation Therapy

Chelation with disodium EDTA, an intravenous compound that binds calcium and metals, has been one of the most debated alternative therapies in cardiology for decades. The idea is simple: infuse a chemical that grabs calcium, and it should pull calcium out of arteries. The reality proved more complicated but not entirely discouraging.

The Trial to Assess Chelation Therapy (TACT), a large government-funded study, enrolled patients who had already had a heart attack. The chelation group experienced cardiovascular events at a modestly lower rate than the placebo group. The study’s authors themselves said the results “provide evidence to guide further research but are not sufficient to support the routine use of chelation therapy.”

13JAMA. Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction

Where chelation showed its most striking results was in a subgroup of patients with diabetes. Among those with both diabetes and peripheral artery disease, the active infusions cut the primary endpoint roughly in half compared to placebo, with a large absolute risk reduction.

14PubMed Central. The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT)

Why patients with diabetes benefited so much more is still debated. One theory is that EDTA’s ability to pull out toxic metals like cadmium and lead, which accumulate at higher levels in people with diabetes, matters as much as or more than its calcium-binding properties.

15Ganesha Medicine. EDTA-Based Chelation Therapy as A Preventive Measure in Patient with Myocardial Infarction: A Literature Review A follow-up trial (TACT2) has been underway to test whether those diabetes-specific benefits hold up. For now, mainstream cardiology guidelines do not recommend chelation for coronary artery disease, though the door has not been fully shut.

Catheter-Based Procedures That Physically Crack Calcium

When calcification is severe enough to block blood flow or prevent a stent from expanding properly, interventional cardiologists have tools to physically deal with it. These do not remove calcium from the body in any systemic sense; they break up or shave away calcium at the specific site of a blockage to restore blood flow.

Atherectomy devices work like tiny drills. Rotational atherectomy uses a diamond-tipped burr spinning at high speed to grind through calcified plaque. Orbital atherectomy uses a similar concept with an eccentrically mounted crown that sands the surface in an orbital motion. A meta-analysis comparing the two found no significant overall difference in major adverse cardiac events, heart attack, or death between the approaches.

16PubMed. Outcomes of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary stenosis: A systematic review and meta-analysis

Intravascular lithotripsy is a newer technique that borrows the technology used to break up kidney stones. A balloon catheter delivers pulsatile sonic waves that crack calcium deposits from the inside, without grinding or cutting. It has been shown to fracture calcium proportional to how much is present, improving stent expansion in both concentrically and eccentrically calcified arteries.

17PubMed Central. Impact of Calcium Eccentricity on the Safety and Effectiveness of Coronary Intravascular Lithotripsy

These procedures are reserved for patients with significant symptoms or dangerous blockages. They are not preventive, and they do not address the underlying process that caused the calcification in the first place. A patient who undergoes atherectomy still needs aggressive management of their risk factors to slow future calcium buildup.

Emerging Drug Therapies

A few newer approaches target calcification from angles that existing drugs do not. SNF472 (myo-inositol hexaphosphate) is a drug designed to bind directly to the surface of hydroxyapatite crystals, preventing additional calcium and phosphate ions from attaching and blocking further crystal growth. It has shown promise in lab models of aortic valve calcification and is being studied in clinical trials for patients on dialysis, who face the most aggressive forms of vascular calcification.

18Vascular Pharmacology. SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification

SGLT2 inhibitors, a class of diabetes drugs that have become major players in heart failure treatment, have shown intriguing signals related to calcification. In patients with aortic stenosis, a condition driven partly by valve calcification, those prescribed SGLT2 inhibitors were less likely to progress to severe disease. Patients on the drugs for more than a year showed the strongest protective effect.

19JACC: Cardiovascular Interventions. Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis

Neither of these approaches has been proven to reverse existing calcification in humans. They represent the direction the field is moving: rather than trying to dissolve established mineral deposits, researchers are trying to stop the active biological process that keeps adding new ones.

Kidney Disease and Accelerated Calcification

Chronic kidney disease (CKD) deserves its own mention because it creates a uniquely hostile environment for arteries. When the kidneys can no longer properly clear phosphate from the blood, phosphate levels rise. That excess phosphate directly stimulates smooth muscle cells to transform into bone-like cells and begin depositing calcium.

20PubMed Central. Hyperphosphatemia of chronic kidney disease

High calcium and high phosphate together are worse than either one alone. Elevated phosphate primarily drives the osteogenic transformation of smooth muscle cells, while elevated calcium promotes cell death and the release of tiny vesicles that seed new mineral deposits. The combination produces a synergistic stimulus that makes vascular calcification in CKD especially aggressive and difficult to manage.

21PubMed Central. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate

Current treatments for CKD-related calcification focus on controlling the mineral imbalances rather than reversing existing deposits. Phosphate binders taken with meals reduce phosphate absorption from food, and strategies to boost pyrophosphate, one of the body’s natural calcification brakes, are under investigation.

3PubMed Central. Vascular Calcification: A Passive Process That Requires Active Inhibition For people with kidney disease, managing phosphate is arguably the single most important thing they can do for their arteries.

Why Calcification Speeds Up After Menopause

Estrogen turns out to be one of the body’s more effective anti-calcification agents, which is why arterial calcium accumulation accelerates sharply in women after menopause. Without estrogen, smooth muscle cells in artery walls are more likely to switch on the same bone-building genes (Runx2 and BMPs) that drive calcification in general. Estrogen also supports the production of matrix Gla protein and suppresses inflammatory signals that promote smooth muscle cell death and calcific nodule formation.

22PubMed Central. Interplay of menopause, coronary artery calcium score and cardiovascular disease risk

This helps explain why premenopausal women have dramatically lower coronary calcium scores than men of the same age, and why that gap closes after menopause. Whether hormone replacement therapy can slow post-menopausal calcification is an active area of research, though the cardiovascular risk-benefit balance of hormone therapy remains complicated for reasons that go well beyond calcification.

The Endurance Exercise Paradox

Exercise is protective against heart disease by almost every measure. Yet a consistent and somewhat unsettling finding has emerged over the past two decades: older men who have spent their lives doing high volumes of endurance exercise, marathon runners, long-distance cyclists, and similar athletes, tend to have more coronary artery calcium than sedentary or moderately active people their age.

23PubMed Central. Paradox of Exercise and Coronary Artery Calcification: Potential Underlying Mechanisms

A study comparing lifelong endurance athletes to controls found the athletes had roughly twice the odds of having at least one calcified coronary plaque.

24European Heart Journal. Lifelong endurance exercise and its relation with coronary atherosclerosis This has understandably alarmed some fitness-minded people. However, the picture is not as grim as the calcium scores suggest. The plaques found in athletes tend to be more calcified and stable, similar to the dense calcium pattern seen with statin use. The working theory is that years of high coronary blood flow and repeated hemodynamic stress trigger remodeling that favors stable, calcified plaque over the soft, rupture-prone type.

25PubMed Central. Exercise-Induced Coronary Remodeling and the Atherosclerotic Paradox in Endurance Athletes: Toward a Unified Mechanobiological Framework

The clinical takeaway is that a high calcium score in a lifelong athlete may not carry the same risk as the same score in a sedentary person. Standard calcium scoring does not distinguish between stable dense calcium and dangerous soft plaque, which is one of the limitations of using the calcium score as a universal risk marker.

Rare Genetic Conditions That Cause Extreme Calcification

For most people, arterial calcification develops gradually over decades under the influence of age, cholesterol, blood pressure, and the other usual suspects. But a handful of rare genetic conditions cause severe vascular calcification far earlier in life, sometimes in infancy. These conditions are caused by mutations in genes that produce the enzymes responsible for generating pyrophosphate, the body’s natural calcification inhibitor. One such gene, ENPP1, is linked to a devastating calcific disorder in infants. Another, NT5E, causes adult-onset calcification of the arteries in the legs.

26PubMed Central. Genetic pathways of vascular calcification

These conditions are extremely rare, but they have been valuable for research because they reveal the biology in its starkest form. If you knock out the body’s natural braking system against calcification, minerals rush into the vessel wall unchecked. Understanding these genetic pathways has directly informed the development of drugs like SNF472 and therapeutic strategies aimed at boosting pyrophosphate levels, ideas that may eventually benefit the far larger population of people whose calcification develops the ordinary way.